HILARY REVIELLO: Open Payments
NPI 1881247088 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $594 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $158 |
| Gilead Sciences, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $109 |
| Novo Nordisk Inc | 1 | $94 |
| ABBVIE INC. | 1 | $63 |
Products named: REZDIFFRA, Livdelzi, IBSRELA, LINZESS.
Industry payments across PA — which companies pay providers there.
